Michela D'Ascanio is an expert in Pulmonology at Sapienza University of Rome (Italy). Michela D'Ascanio has authored 41 publications, the most recent in 2023. SLR score: 112 (community average: 125). How the SLR is computed.

LeadR Profile

Michela D'Ascanio Sapienza University of Rome Italy
112 ScienceLeadR Reputation 112
Network Map

Pulmonology

Subspecialties: Biochemistry - Sleep Medicine Specialty

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2017 - 2024

Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 41

Citations

Citations: 528 1st author: 7 Last author: 7 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Short-Term Benefits of Smoking Cessation Improve Respiratory Function and Metabolism in Smokers.
PMID 38059013 — vitamins, smokers, pulmonary disease, chronic obstructive, cholesterol, smoking cessation, smoke, therapeutics, smoking
Int J Chron Obstruct Pulmon Dis202349
Surfactant Protein B Plasma Levels: Reliability as a Biomarker in COPD Patients.
PMID 36672632 — pulmonary disease, chronic obstructive, plasma, signs and symptoms, biomarkers, spirometry, enzyme-linked immunosorbent assay
Biomedicines20237
Histologic Analysis of Idiopathic Pulmonary Fibrosis by Morphometric and Fractal Analysis.
PMID 37239155 — research design, pneumonia, biopsy, lung, idiopathic pulmonary fibrosis, tissues
Biomedicines20235
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients.
PMID 35584864 — cells, lung, pleural effusion, tumor escape, macrophages, neoplasms, adenocarcinoma, carcinoma, non-small-cell lung, adenocarcinoma of lung, immunotherapy, lung neoplasms, tumor microenvironment, computational biology, plasma, pleural effusion, malignant
J Immunother Cancer202210
B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis.
PMID 36499368 — biomarkers, cells, lung neoplasms, immunohistochemistry, biopsy, genes, idiopathic pulmonary fibrosis
Int J Mol Sci20228

LeadR Networks

Main global connection map